Innovative Hydrogen Exploration Program Launch in Ontario's Timiskaming District
Key Ideas
- DiagnaMed, in collaboration with INRS and QIMC, is reviewing geological data to identify target zones for a soil gas sampling program in Ontario's Timiskaming district.
- The company aims to replicate the success of the hydrogen discovery in Quebec by applying a similar model in Ontario, focusing on natural hydrogen and helium generation.
- The exploration strategy prioritizes areas with geological structures conducive to gas migration and trapping, indicating substantial potential for hydrogen and helium extraction.
- Engagement of Independent Trading Group (ITG) will enhance liquidity for DiagnaMed shares, contributing to the company's market presence and investor engagement.
DiagnaMed Holdings Corp., a Canadian technology innovator specializing in advanced hydrogen extraction technologies, is advancing its program in Ontario's Timiskaming district in preparation for an upcoming soil gas sampling campaign. In collaboration with INRS and QIMC, the company is conducting a comprehensive review of geological data to identify high-priority target zones across strategically acquired claims in Northern Ontario. The exploration strategy is based on a geological framework favorable for natural hydrogen (H₂) and helium (He) generation, focusing on areas with the presence of key geological structures such as rift and graben systems, fault systems, and specific rock formations known for being favorable sources for H₂ and He.
The company's claim selection strategy is supported by documented seismicity data, indicating tectonic activity that may enhance subsurface gas circulation. By leveraging successful models from the Quebec side of the Timiskaming graben, DiagnaMed aims to replicate the hydrogen discovery in the region. The targeted exploration area includes Armstrong, Brethour, Whitewood Grove, and Tomstown, where the company holds extensive exploration permits.
Moreover, DiagnaMed has engaged Independent Trading Group (ITG) Inc. to provide market-making services, enhancing liquidity for its shares. This partnership aims to maintain a reasonable market for DiagnaMed shares through active trading of common shares by ITG. The collaboration with ITG will contribute to improving market presence and investor engagement for DiagnaMed.
John Karagiannidis, the President and CEO of DiagnaMed, expressed confidence in the potential of the exploration program in Ontario, highlighting the company's successful model from Quebec and the expertise of INRS in identifying promising structures for hydrogen extraction. The initiative signifies a significant step towards expanding DiagnaMed's presence in the natural hydrogen industry, crucial for global energy security and decarbonization.